Australian Dry Eye

Click here to edit subtitle

Active Clinical Trials

For more information or to participate, please click on the relevant trial and connect directly with the recruiters via email or phone. A complete list of all clinical trials can be found here.

United States








Singapore

Ongoing Research

TearSolutions (USA) - Lacripep

Norvartis (USA/EU) - LubricinSAF-312

University of New South Wales (Australia) - Atorvastatin

Sylentis (Spain) - Tivanisiran

IACTA Pharma (USA) - IC265DENKI

Proteris Biotech (USA) - Protearin

Mimtogen (Canada) - Taverlimide

Neuroptika (USA) - NRO-1

Dompé (Italy) - TRPM8, Platform IL-8, rhNGF

Azura Ophthalmics (Australia/Israel) - MD-001, MD-002, BL-007

RegeneRx (USA) - RGN-259

Tarsus (USA) - TP-03

Oyster Point (USA) - OC-01

Silk-Tech (USA) - SDP-4

Axalbion (Switzerland) - TRPM8

Parion Sciences (USA) - P-321

Kala Pharmaceuticals (USA) - Eyesuvis

Aldeyra Therapeutics (USA) - Rexproxalap

Pharmaleads (France) - PL265

University of Illinois (USA) - DNase

Oculis (Iceland) - OCS-02

Redwood Pharma (Sweden) - RP-101

Aerie Pharmaceuticals (USA) - AVX-012, JAKi/IKKbi

Nicox (USA) - NCX-4251

OKYO Pharma (USA) - Chermerin

Xigen (Switzerland) - XG-102, XG-104

Palatin Technologies (USA) - PL9643

Aviara Pharmaceuticals (USA) - AVA3486

Ocunova (USA) - OCU-001

Biozep (Norway) - BIZ-101

OccuRX (Australia) - OCX-071

SiteOne Therapeutics (USA) - ST Topical

Allegro Ophthalmics (USA) - ALG-1007

BRIM Biotechnology (South Korea) - BRM-421

Allysta (USA) - ALY-688

Inflamalps (Switzerland) - INF101

Akari Therapeutics - Coversin

Quorum Innovations (USA) - Qi-401

Bessor Pharma (USA) - TSG-06

AxeroVision (USA) - AXR-159, AXR-270

VivaVision (China) - VN001

Abbvie (USA) - AGN-242428, AGN-231868